Back to search

Predicting the biologic behavior of ductal carcinoma in situ: An analysis of molecular markers

Data up to Jan 2025

Published2001
Citations37
References24

Total Citations Per Year

Abstract

References (24)

Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma

1991 • 5,657 citations

Vascular endothelial growth factor (VEGF) and its receptors

1999 • 3,498 citations

Cancer Statistics, 2001

2001 • 3,342 citations

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

1995 • 1,863 citations

Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice

1999 • 990 citations

How Tumors Become Angiogenic

1996 • 514 citations

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17

1999 • 512 citations

Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.

1999 • 361 citations

Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast.

1996 • 361 citations

Microvessel Density and Distribution in Ductal Carcinoma In Situ of the Breast

1994 • 287 citations

Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.

2000 • 231 citations

Vascular permeability factor (Vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast

1997 • 216 citations

p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein

1993 • 157 citations

Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein

1995 • 132 citations

Distinct Angiogenic patterns are associated with high-gradein situ ductal carcinomas of the breast

1997 • 110 citations

Independent association of angiogenesis index with outcome in prostate cancer.

2001 • 108 citations

Immunophenotype of intraductal carcinoma.

1996 • 77 citations

p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.

1998 • 66 citations

p53 protein expression in ductal carcinoma in situ (DCIS) of the breast

1997 • 42 citations

In microdissected ductal carcinoma in situ, HER-2/neu amplification, but notp53 mutation, is associated with high nuclear grade and comedo histology

2000 • 41 citations

Biological Profile of in Situ Breast Cancer Investigated by Immunohistochemical Technique

1998 • 41 citations

Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy

2000 • 38 citations

Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy

2000 • 31 citations

Microvessel density, proliferating activity, p53 and bcl-2 expression in in situ ductal carcinoma of the breast.

2000 • 23 citations

Cited By (0)

No citing papers found in database

Predicting the biologic behavior of ductal carcinoma in situ: An analysis of molecular… (2001) – Surgery | Metascience Observatory Explorer